Heart Team Philippines: To The Mountain Top!

Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) is the treatment most likely to achieve prolonged survival for peritoneal surface disease from various primaries, yet management of peritoneal sarcomatosis is controversial as a result of the propensity of sarcomas for hematogenous spread and the paucity of effective chemotherapy. Therefore, we reviewed our experience in patients with sarcomatosis.

We propose adoption of an easier and clinically useful metric to assess cannula performance: Q at 100 mm Hg P, the updated M number, or the "UM number."